Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection

Area of Science:

• Neurology
• Immunology
• Infectious Diseases

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is linked to various neurological conditions.
• Demyelinating disorders, such as multiple sclerosis (MS), are among the neurological complications observed post-SARS-CoV-2 infection.

Observation:

• This report details two cases where multiple sclerosis (MS) onset and relapse occurred shortly after SARS-CoV-2 infection.
• Magnetic resonance imaging (MRI) revealed extensive active lesions in the subcortical and periventricular regions in both patients.
• Serological tests confirmed SARS-CoV-2 Spike antigen seroconversion, indicating recent infection.

Findings:

• The study observed a temporal association between SARS-CoV-2 infection and the initiation or exacerbation of multiple sclerosis.
• Active inflammatory responses potentially driven by SARS-CoV-2 infection are hypothesized to contribute to MS onset or relapse.
• The findings suggest a possible role for viral infections in the pathogenesis of autoimmune demyelinating diseases.

Implications:

• The data underscore the importance of considering SARS-CoV-2 infection as a potential trigger for neurological autoimmune disorders.
• Vaccination against SARS-CoV-2 is emphasized as a critical preventive measure for individuals diagnosed with multiple sclerosis.
• Further research is warranted to elucidate the precise mechanisms linking viral infections to demyelinating diseases.